Clinical attachment loss

Clinical attachment loss is one of the three characteristic factors of periodontitis. In clinical practice, CAL is the primary feature assessed to diagnose periodontitis.

Periodontitis is diagnosed when

• CAL interdentally is >2mm on at least 2 non-adjacent teeth
• CAL buccally/orally is >3mm with pocket depths of >3mm on at least two teeth.

As periodontitis is not the sole cause of clinical attachment loss, any CAL attributed to the following factors is not considered during diagnosis.^[8]

• Trauma
• Dental caries extending cervically
• Malposition/Extraction of third molar
• Endodontic Lesion draining through marginal periodontium
• Vertical Root Fracture

The most recent (2017) periodontal disease classification uses CAL as a major factor in assessing both Severity and Progression. Alongside other factors like radiographic bone loss and tooth loss.^[2] CAL correlates to severity (Staging) as follows.

• Stage I: 1-2mm CAL
• Stage II : 3-4mm CAL
• Stage III/IV : >5mm CAL

An increase in CAL is considered direct evidence of progression (Grading) as follows

• Grade A: No change in CAL over the past 5 years
• Grade B: <2mm increase in CAL over the past 5 years
• Grade C:  ≥2mm increase in CAL over the past 5 years

Periodontal therapy focuses primarily on preventing further attachment loss and managing its consequences. Because attachment loss itself is permanent and cannot be reduced, patients who present with CAL are considered lifelong periodontitis patients. ^[9]

Successful periodontal therapy aims to restore the stability of the periodontium, which is accomplished when gingival inflammation ceases and is not reliant on CAL.

Clinical attachment level (CAL), also known as clinical attachment loss, is a periodontal parameter used to determine the position of the periodontal supporting tissues in relation to a fixed point on the tooth, which is the cementoenamel junction (CEJ). Clinical attachment level represents the loss or gain of attachment that occurs due to periodontal disease, treatment, or other conditions such as recession or inflammation.

Pocket depth is the distance from the gingival margin to the base of the pocket. The position of the gingival margin can change due to swelling or recession, and vary with inflammation if force of probing, therefore, probing depth measurement alone is not recommended for assessment of changes in periodontal support over time.

The clinical attachment level (CAL) combines the measurements of probing pocket depth and any gingival recession to give an overall indication of where the periodontal tissues attach to the root surface. It is measured from a constant reference point, usually the CEJ, to the base of the periodontal pocket.  Due to the more stable and reproducible property, this is considered the best measure of changes in residual periodontal support over time.^[1][2]

References: ^[1][3]

Clinical attachment loss (CAL) is a critical parameter in periodontal diagnosis, as it reflects true periodontal tissue destruction. However, increased probing depth does not always indicate attachment loss. Conditions such as pseudopockets and gingival enlargement can mimic periodontal pockets clinically, leading to diagnostic confusion. This part of the article discusses CAL in comparison with pseudopockets and gingival enlargement, highlighting their pathogenesis, clinical features, and diagnostic significance.

Clinical attachment loss refers to the loss of periodontal attachment due to apical migration of the junctional epithelium (JE), accompanied by destruction of gingival connective tissue fibers and periodontal ligament fibers. This results in the formation of a true periodontal pocket, where the base of the pocket lies apical to the cementoenamel junction (CEJ). CAL develops through a complex host–microbial interaction, beginning with microbial dysbiosis, commonly involving anaerobic pathogens such as Porphyromonas gingivalis. This dysbiotic biofilm triggers an exaggerated host immune response, characterized by neutrophil infiltration, pro-inflammatory cytokine release, and complement activation.

With chronic inflammation, destructive enzymes such as matrix metalloproteinases are activated, leading to the breakdown of gingival connective tissue fibers and detachment from the cementum. This allows the JE to migrate apically, deepening the periodontal pocket and facilitating further bacterial invasion. Simultaneously, inflammatory mediators stimulate RANKL-mediated osteoclast activation, resulting in alveolar bone resorption. Biologically, this process is irreversible, involving permanent breakdown of the JE, connective tissue fibers, periodontal ligament, and supporting bone. Clinically, CAL is the gold standard for diagnosing periodontitis and marks the transition from gingivitis to established periodontal disease.^[10]

In contrast, a pseudopocket is characterized by increased probing depth without attachment loss. It represents a false pocket, where the apparent deepening of the sulcus occurs due to coronal displacement of the gingival margin rather than apical migration of the JE. Pseudopockets develop primarily from inflammatory gingival edema or hyperplasia, most often secondary to plaque accumulation. Inflammation causes vascular congestion and collagen breakdown within the gingival connective tissue, resulting in swollen, soft, and puffy gingiva that bulges coronally.

In pseudopockets, the JE remains at its normal position at the CEJ, and the connective tissue attachment remains intact. There is no alveolar bone loss, and the increased probing depth is solely due to gingival swelling. Clinically, pseudopockets are considered an early and reversible stage of periodontal disease, typically associated with gingivitis. However, if plaque accumulation persists, pseudopockets may progress to true periodontal pockets with CAL.^[11]

While CAL represents true periodontal destruction, gingival enlargement refers to an increase in the size of the gingival tissues, which may or may not be associated with attachment loss. In CAL, the gingival margin often migrates apically, leading to gingival recession and increased CEJ–JE distance. The probing depth increases due to a combination of attachment loss and bone loss, and the CEJ is usually clinically visible.

Gingival enlargement, on the other hand, usually results in a false pocket, as the gingival margin moves coronally and covers the CEJ. The probing depth increases due to tissue overgrowth rather than periodontal attachment loss. Attachment and bone loss are typically absent unless gingival enlargement coexists with periodontitis.

The pathogenesis of gingival enlargement varies depending on the underlying cause. Inflammatory gingival enlargement is commonly associated with plaque, calculus, ill-fitting restorations, orthodontic appliances, or fractured teeth. The gingiva may appear red or bluish, soft, friable, and may become firm if the condition becomes chronic. Drug-induced gingival enlargement is commonly associated with anticonvulsants such as phenytoin, immunosuppressants like cyclosporine, and calcium channel blockers such as nifedipine. These cases typically present as firm, pink, bead-like gingiva, often more prominent in the anterior regions.

Genetic or syndromic gingival enlargement, such as Zimmermann-Laband or Ramon syndrome, presents as firm, fibrotic, and persistent nodular gingival overgrowth that usually begins around tooth eruption. Systemic or hormonal causes, including pregnancy, hormonal imbalance, leukemia, granulomatosis with polyangiitis (strawberry gingivitis), and vitamin C deficiency, can also result in gingival enlargement. In rare cases, gingival enlargement may be neoplastic, such as in squamous cell carcinoma or fibroma.

Clinically, gingival enlargement often obscures the CEJ, and the gingival margin appears coronally positioned. Unlike CAL, gingival enlargement is often reversible or manageable once the underlying cause is addressed, though surgical correction may be required in fibrotic or genetic cases.^[12]

Patients with clinical attachment loss typically present with features of chronic periodontitis. A common example is a middle-aged adult with deep true periodontal pockets, gingival recession, tooth mobility, furcation involvement, and radiographic evidence of alveolar bone loss. Another example includes localized attachment loss due to aggressive toothbrushing, presenting as cervical recession with exposed CEJ and true pocket formation. Key identifying features include irreversible attachment loss, apical migration of the JE, and true periodontal pocket formation.

Pseudopockets are commonly seen in younger patients with plaque-induced gingivitis. For example, a teenager may present with swollen, edematous gingiva, probing depths of 6–10 mm, a hidden CEJ, and no radiographic bone loss. Similarly, patients with orthodontic brackets may develop localized gingival swelling around brackets, resulting in 5–7 mm probing depths without attachment loss. These cases are characterized by false pockets, increased probing depth due solely to gingival swelling, and reversibility with proper plaque control.

Gingival enlargement presents differently depending on etiology. Drug-induced cases, such as in patients taking phenytoin or nifedipine, show bulbous, firm, bead-like gingiva with buried CEJs and minimal bleeding on probing. Hormonal enlargement, such as pregnancy epulis, appears as localized, red, soft, and friable gingival masses with partially hidden CEJs and increased sulcus depth. Genetic gingival enlargement presents in children with firm, fibrotic, generalized gingival overgrowth beginning around tooth eruption, often requiring surgical management. These cases are identified by tissue overgrowth-related pseudopocket formation and generally intact periodontal attachment.